Biofrontera Inc.
1.03
-0.02 (-1.90%)
At close: Jan 15, 2025, 10:53 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -20.13M -640.00K -37.71M -10.99M -10.98M
Depreciation & Amortization 1.06M 1.17M 540.00K 562.00K 667.00K
Stock-Based Compensation 1.04M 1.85M 129.00K n/a n/a
Other Working Capital -11.99M 4.76M -2.71M -321.00K -21.08M
Other Non-Cash Items -2.48M -21.37M -1.04M 883.00K -3.42M
Deferred Income Tax n/a n/a 12.88M n/a n/a
Change in Working Capital -4.39M 2.79M -1.50M -2.83M -23.94M
Operating Cash Flow -24.89M -16.20M -26.71M -12.37M -37.68M
Capital Expenditures -5.00K -38.00K -11.00K n/a -538.00K
Acquisitions n/a n/a n/a n/a 25.93M
Purchase of Investments n/a -5.12M n/a n/a n/a
Sales Maturities Of Investments 624.00K n/a n/a n/a n/a
Other Investing Acitivies n/a -5.12M n/a n/a n/a
Investing Cash Flow 619.00K -5.16M -11.00K n/a 25.39M
Debt Repayment 3.90M n/a n/a 8.79M 13.50M
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies n/a 4.63M 13.25M 4.40M 2.90M
Financial Cash Flow 8.41M 14.02M 43.19M 13.19M 16.40M
Net Cash Flow -15.87M -7.33M 16.46M 825.00K 4.12M
Free Cash Flow -24.90M -16.24M -26.73M -12.37M -38.22M